Owner Institut Pasteur De Lille Institut National de la Sante et de la Recherche Medicale (INSERM)

Inventors Locht, Camille; Menozzi, Franco; Pethe, Kevin

Agent Cullen & Co

Pub. Number AU-B-2002360178

PCT Number PCT/FR02/03942

PCT Pub. Number WO2003/044048

Priority 01/14953 19.11.01 FR

Filing date 18 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 17 April 2008

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/35 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione